Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 13, 2017
High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant TherapyMarina Willibald, Isabel Wurster, Christoph Meisner, et al.Menopause (New York, N.Y.)|October 18, 2016
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancerXiangyan Ruan, Ying Zhang, Alfred O Mueck, et al.International Journal of Clinical and Experimental Pathology|January 2, 2016
ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancerBo Ma, Qianqian Ma, Chunhui Jin, et al.Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Progestin effects in endometriosis treatment: new research on mechanismsAlfred O MueckTherapeutische Umschau. Revue Therapeutique|September 24, 2021
[Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)]Alfred O MueckGynakologisch-Geburtshilfliche Rundschau|October 28, 2006
[Hormone replacement therapy for internal risk patients]Alfred O MueckMaturitas|July 17, 2013
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1Jing Zhou, Qi Yu, Rong Chen, et al.Menopause (New York, N.Y.)|May 3, 2011
The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cellsHans Neubauer, Yang Yang, Harald Seeger, et al.Maturitas|June 15, 2017
The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft modelYue Zhao, Xiangyan Ruan, Husheng Wang, et al.Hormone Molecular Biology and Clinical Investigation|August 1, 2018
Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal womenAlfred O Mueck, Thomas RömerPageof 22